Details have been released about the production of the Russian Sputnik V vaccine in Turkey, developed against COVID-19. VisCoran Ilac Sanayii AS has signed a deal with the Russian Direct Investment Fund (RDIF) on the vaccine’s manufacturing rights and is in negotiation with four Turkish companies Polfarma, Mefar, Onko and Arven – which have received Good Manufacturing Practice (GMP) approval, according to Ozturk Oran, Board Chairman of VisCoran Ilac Sanayii AS. After 9 months of negotiations with the Russians, VisCoran Ilac Sanayii AS plans to approach these four companies if they obtain a highcapacity manufacturing “We agreed with them in principle. We are discussing the details now,” Oran said.
The CAD is big and its financing is bad!
To what extent does the misery index influence voters’ choices?
AI and beyond
Budget deficit risk of around 7% of GDP
Tourism revenues rise higher than the number of tourists
Need for anchor
Patents with technological advances in the automotive ecosystem
Let’s estimate FX rates…
Inflation soared while the policy rate was lowered
Famous banks’ election expectations
Energy and gold don’t explain the CAD
Levent Kafkasli becomes GM of GAP Insaat
Global tension: Is it decision time for Turkey?
When you don’t learn from a mistake from 30 years ago
UNDP sends containers to the quake-hit region
Annualized foreign trade deficit tripled in 1.5 years
KKM, liraization: Fiddlesticks!
Capacity usage down contrary to real sector confidence
Turkey at a Glance
SPUTNIK V VACCINE RECEIVES APPROVAL FOR PRODUCTION IN TURKEY
February 1, 2021March 15, 2021
Leave a Reply